Paper · 39506152
Coordinated inheritance of extrachromosomal DNAs in cancer cells.
Hung KL and 24 others. Nature, 2024. Cited by 88 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Coordinated inheritance of extrachromosomal DNAs in cancer cells. Papers, record 39506152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39506152
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extrachromosomal Inheritance | Major topic |
| Mitosis | Major topic |
| Neoplasms | Major topic |
| DNA | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Epigenesis, Genetic | |
| Gene Dosage | |
| Models, Genetic | |
| Oncogenes | |
| Single-Cell Analysis | |
| Transcription, Genetic |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K99 CA286968 | NCI NIH HHS | United States | K99CA286968 | PubMed and NIH | NIH RePORTER |
| U24 CA264379 | NCI NIH HHS | United States | U24CA264379 | PubMed and NIH | NIH RePORTER |
| CGCATF-2021/100012 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| OT2 CA278635 | NCI NIH HHS | United States | OT2CA278635 | PubMed and NIH | NIH RePORTER |
| R01 GM114362 | NIGMS NIH HHS | United States | R01GM114362 | PubMed and NIH | NIH RePORTER |
| F99CA274692 | NIH | NIH RePORTER | |||
| OT2CA278644 | NIH | NIH RePORTER | |||
| OT2CA278670 | NIH | NIH RePORTER | |||
| OT2CA278688 | NIH | NIH RePORTER | |||
| OT2CA278692 | NIH | NIH RePORTER |
1 to 10 of 12
See all 12 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 37,503,111 | Coordinated inheritance of extrachromosomal DNA species in human cancer cells. | https://conductscience.org/library/papers/37503111 |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,409,389 | Extrachromosomal DNA in cancer. | Nat Rev Cancer | 2024 | https://conductscience.org/library/papers/38409389 | PubMed |
| 2 | 34,819,668 | ecDNA hubs drive cooperative intermolecular oncogene expression. | Nature | 2021 | https://conductscience.org/library/papers/34819668 | PubMed |
| 3 | 28,178,237 | Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. | Nature | 2017 | https://conductscience.org/library/papers/28178237 | PubMed |
| 4 | 34,680,928 | Gene Amplification and the Extrachromosomal Circular DNA. | Genes (Basel) | 2021 | https://conductscience.org/library/papers/34680928 | PubMed |
| 5 | 3,856,243 | Ultrastructural features of minute chromosomes in a methotrexate-resistant mouse 3T3 cell line. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3856243 | PubMed |
| 6 | 24,310,612 | Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. | Science | 2014 | https://conductscience.org/library/papers/24310612 | PubMed |
| 7 | 903,253 | Experimental elimination and recovery of double minute chromosomes in malignant cell populations. | Hereditas | 1977 | https://conductscience.org/library/papers/903253 | PubMed |
| 8 | 29,686,388 | Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma. | Nat Genet | 2018 | https://conductscience.org/library/papers/29686388 | PubMed |
| 9 | 649,427 | Have double minutes functioning centromeres? | Hereditas | 1978 | https://conductscience.org/library/papers/649427 | PubMed |
| 10 | 18,769,732 | Binomial mitotic segregation of MYCN-carrying double minutes in neuroblastoma illustrates the role of randomness in oncogene amplification. | PLoS One | 2008 | https://conductscience.org/library/papers/18769732 | PubMed |
1 to 10 of 65
See all 65 referencesCited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,897,892 | Profiling Extrachromosomal Circular DNA (ecDNA) in Cancer via Next-Generation Sequencing: A New Frontier in Tumor Evolution and Therapy Resistance. | Anticancer Agents Med Chem | 2026 | https://conductscience.org/library/papers/42897892 | PubMed |
| 42,888,240 | AmpliconSuite: an end-to-end workflow for analyzing focal amplifications in cancer genomes. | Nat Methods | 2026 | https://conductscience.org/library/papers/42888240 | PubMed |
| 42,864,499 | Micronuclear ecDNA constrains tumor cell fitness and is associated with favorable patient survival. | Nat Genet | 2026 | https://conductscience.org/library/papers/42864499 | PubMed |
| 42,827,107 | Single-cell epigenomics of colorectal cancer. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42827107 | PubMed |
| 42,826,715 | An epigenetic program dictates MYC amplification dynamics that promote transient, extrachromosomal, and inherited genomic events. | Mol Cell | 2026 | https://conductscience.org/library/papers/42826715 | PubMed |
| 42,818,635 | Quantitative and sensitive neuroblastoma minimal residual disease detection using extrachromosomal DNA (ecDNA) breakpoints. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818635 | PubMed |
| 42,816,857 | Extrachromosomal DNA as a platform for epigenetic reprogramming in cancer. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42816857 | PubMed |
| 42,778,593 | MMEJ repair of breaks at TA repeats maintains ecDNA and cancer fitness. | Nature | 2026 | https://conductscience.org/library/papers/42778593 | PubMed |
| 42,736,483 | The shared evolutionary capacities of plasmids and extrachromosomal DNA. | Nat Rev Genet | 2026 | https://conductscience.org/library/papers/42736483 | PubMed |
| 42,706,270 | scAmp enables focal gene amplification analysis from single-cell data. | Nat Commun | 2026 | https://conductscience.org/library/papers/42706270 | PubMed |
1 to 10 of 70
See all 70 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE159986 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39506152
GET https://conductscience.org/api/papers/v1/39506152/authors?page=2